Determination of Level of 25-Hydroxy Vitamin D3 in Patients with Multiple Sclerosis and Its Effect on Disease Activity

The current study was focused on patients with Multiple sclerosis between the ages group of 20 - 60. The objective of this study is to decide the level of 25-hydroxyvitamin D3 status in patients with multiple sclerosis (MS) and its engagement, with disease activity. A total of 31 cases have participated from Baghdad Teaching Hospital in Baghdad, Iraq during the period between March and April 2018. The results shows that, only significant finding was that, supplements for Vitamin D significantly increased its mean level in patients with Multiple Sclerosis (P < 0.05)